- Home
- VIGL vs PIM Comparison
VIGL vs PIM Comparison
Compare VIGL & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- PIM
- Stock Information
- Founded
- VIGL 2020
- PIM 1988
- Country
- VIGL United States
- PIM United States
- Employees
- VIGL N/A
- PIM N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- PIM Finance Companies
- Sector
- VIGL Health Care
- PIM Finance
- Exchange
- VIGL Nasdaq
- PIM Nasdaq
- Market Cap
- VIGL 134.9M
- PIM 161.4M
- IPO Year
- VIGL 2022
- PIM N/A
- Fundamental
- Price
- VIGL $8.05
- PIM $3.33
- Analyst Decision
- VIGL Buy
- PIM
- Analyst Count
- VIGL 7
- PIM 0
- Target Price
- VIGL $8.00
- PIM N/A
- AVG Volume (30 Days)
- VIGL 1.1M
- PIM 57.5K
- Earning Date
- VIGL 08-12-2025
- PIM 01-01-0001
- Dividend Yield
- VIGL N/A
- PIM 8.28%
- EPS Growth
- VIGL N/A
- PIM N/A
- EPS
- VIGL N/A
- PIM 0.05
- Revenue
- VIGL N/A
- PIM N/A
- Revenue This Year
- VIGL N/A
- PIM N/A
- Revenue Next Year
- VIGL N/A
- PIM N/A
- P/E Ratio
- VIGL N/A
- PIM $63.80
- Revenue Growth
- VIGL N/A
- PIM N/A
- 52 Week Low
- VIGL $1.31
- PIM $2.90
- 52 Week High
- VIGL $8.06
- PIM $3.28
- Technical
- Relative Strength Index (RSI)
- VIGL 88.18
- PIM 51.79
- Support Level
- VIGL $7.86
- PIM $3.34
- Resistance Level
- VIGL $8.05
- PIM $3.35
- Average True Range (ATR)
- VIGL 0.02
- PIM 0.03
- MACD
- VIGL -0.15
- PIM 0.00
- Stochastic Oscillator
- VIGL 73.15
- PIM 63.64
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.